Novan Inc logo

Novan Inc

$ 1.74 -0.08 (-4.4%) 10:32 AM EST
P/E:
At Loss
P/B:
3.00
Market Cap:
$ 37.03M
Enterprise V:
$ 18.88M
Volume:
44.05K
Avg Vol (2M):
144.88K
Also Trade In:
Volume:
44.05K
Market Cap $:
37.03M
PE Ratio:
At Loss
Avg Vol (2-Month):
144.88K
Enterprise Value $:
18.88M
PB Ratio:
3.00
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Novan Inc is a clinical-stage biotechnology company. It is engaged in developing therapies based on nitric oxide for treating dermatology and oncovirus related diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 1.83
Equity-to-Asset 0.11
Debt-to-Equity 1.67
Debt-to-EBITDA -0.59
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.24
Distress
Grey
Safe
Beneish M-Score 119.35
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.96
9-Day RSI 33.3
14-Day RSI 31.73
6-1 Month Momentum % -37.31
12-1 Month Momentum % -68.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.4
Quick Ratio 1.37
Cash Ratio 0.84
Days Inventory 196.68
Days Sales Outstanding 299.51
Days Payable 476.6

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -93.3

Financials (Next Earnings Date:2022-11-10 Est.)

NOVN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NOVN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 9.478
EPS (TTM) ($) -1.93
Beta 0.09
Volatility % 51.88
14-Day RSI 31.73
14-Day ATR ($) 0.149698
20-Day SMA ($) 2.0945
12-1 Month Momentum % -68.77
52-Week Range ($) 1.67 - 7.87
Shares Outstanding (Mil) 21.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novan Inc Filings

Document Form Filing Date
No Filing Data

Novan Inc Analysis

Share your research

Headlines

See More
No news.